Morus raised $5 Million in Series A funding, accelerating global expansion and R&D of silkworm-derived bioingredients
Morus Inc., a Japan-based R&D-driven bioingredient manufacturer (H…
MORE
News
Morus awarded at the Forbes Asia 100 to Watch Forum 2025
Morus Inc. (Headquarters: Chiyoda-ku, Tokyo; Representative Director a…
MORE
Morus exhibited and presented at Expo 2025 Osaka, Kansai, Japan
Morus Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Ryo Sato) is pleased…
MORE
Morus exhibited and presented at Expo 2025 Osaka, Kansai, Japan
Morus Inc. (Headquarters: Tokyo; Representative Director and CEO: Ryo …
MORE
Morus selected for NEXT IMPACT STARTUPS 30 of Forbes JAPAN 2025
Morus Inc. (Headquarters: Tokyo; Representative Director and CEO: Ryo …
MORE
Morus selected for JETRO’s Japan Pavilion at AFTEA 2024
Morus Inc. (Headquarters: Tokyo; Representative Director and CEO: Ryo …
MORE
Morus selected for Forbes Asia 100 to Watch 2024
Morus Inc. (Headquarters: Tokyo; Representative Director and CEO: Ryo …
MORE
Morus featured as a leading startup on the Prime Minister’s YouTube channel
We are pleased to announce that Morus has been featured on the officia…
MORE
Morus selected as a Finalist for the Southeast Asia Capital Access Program
Morus Inc. (Headquarters: Tokyo; Representative Director and CEO: Ryo …
MORE
Morus featured in Singapore’s leading business newspaper
The Business Times featured our product launch in Singapore on the fro…
MORE